Log in to save to my catalogue

HBsAg和抗HBs双阳性患者S基因新增N-糖基化突变的意义

HBsAg和抗HBs双阳性患者S基因新增N-糖基化突变的意义

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_chongqing_primary_669018779

HBsAg和抗HBs双阳性患者S基因新增N-糖基化突变的意义

About this item

Full title

HBsAg和抗HBs双阳性患者S基因新增N-糖基化突变的意义

Journal title

解放军医学杂志, 2016, Vol.41 (5), p.351-357

Language

Chinese

Formats

More information

Scope and Contents

Contents

目的分析乙型肝炎病毒(HBV)HBsAg+抗HBs双阳性患者S基因主要亲水区(MHR)新增N-糖基化突变的特点,探讨HBsAg+抗HBs双阳性的发生机制和临床意义。方法对284例HBsAg+抗HBs双阳性和314例HBsAg单阳性的慢性HBV感染者S基因进行测序分析。对1例携有MHR区双N-糖基化新型突变株的慢性乙肝患者样本进行随访收集和研究。构建双N-糖基化突变和对照前S/S基因重组质粒,转染HepG2细胞,分析突变对病毒复制力和抗原性的影响。结果 HBsAg+抗HBs双阳性患者MHR区新增N-糖基化突变的检出率为11.3%(32/284),显著高于HBsAg单阳性患者的2.9%(9/314)(P〈0.01)。HBsAg+抗HBs双阳性组中,72例肝细胞癌(HCC)在N-糖基化突变阳性和阴...

Alternative Titles

Full title

HBsAg和抗HBs双阳性患者S基因新增N-糖基化突变的意义

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_chongqing_primary_669018779

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_chongqing_primary_669018779

Other Identifiers

ISSN

0577-7402

How to access this item